DarioHealth Corp. Investment Income, Interest
DarioHealth Corp. (DRIO) reported Investment Income, Interest of $135.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-11
- DarioHealth Corp. investment income, interest for the quarter ending 2026-06-30 was $135.00K, a 43.04% decline year-over-year.
- DarioHealth Corp. investment income, interest for the quarter ending 2026-03-31 was $160.00K, a 44.64% decline year-over-year.
- DarioHealth Corp. investment income, interest for the quarter ending 2025-12-31 was $242.00K, a 50.31% increase year-over-year.
- DarioHealth Corp. investment income, interest for the quarter ending 2025-09-30 was $175.00K, a 22.57% decline year-over-year.
- DarioHealth Corp. investment income, interest for fiscal 2025 was $943.00K, a 15.50% decline from fiscal 2024.
- DarioHealth Corp. investment income, interest for fiscal 2024 was $1.12M, a 40.26% decline from fiscal 2023.
- DarioHealth Corp. investment income, interest for fiscal 2023 was $1.87M, a 269.17% increase from fiscal 2022.
- DarioHealth Corp. investment income, interest for fiscal 2022 was $506.00K, a 1050.00% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $135.00K 10-Q · filed 2026-08-11 | $294.00K 10-Q · filed 2026-08-11 | $537.00K derived: sum of 3 quarters · filed 2026-08-11 | $712.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $160.00K 10-Q · filed 2026-05-13 | $402.00K derived: sum of 2 quarters · filed 2026-05-13 | $577.00K derived: sum of 3 quarters · filed 2026-05-13 | $814.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $417.00K derived: sum of 2 quarters · filed 2026-03-19 | $654.00K derived: sum of 3 quarters · filed 2026-08-11 | $943.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $175.00K 10-Q · filed 2025-11-13 | $412.00K derived: sum of 2 quarters · filed 2026-08-11 | $701.00K 10-Q · filed 2025-11-13 | $862.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $237.00K 10-Q · filed 2026-08-11 | $526.00K 10-Q · filed 2026-08-11 | $687.00K derived: sum of 3 quarters · filed 2026-08-11 | $913.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $289.00K 10-Q · filed 2026-05-13 | $450.00K derived: sum of 2 quarters · filed 2026-05-13 | $676.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.01M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $387.00K derived: sum of 2 quarters · filed 2026-03-19 | $726.00K derived: sum of 3 quarters · filed 2026-03-19 | $1.12M 10-K · filed 2026-03-19 |
| 2024-09-30 | $226.00K 10-Q · filed 2025-11-13 | $565.00K derived: sum of 2 quarters · filed 2025-11-13 | $955.00K 10-Q · filed 2025-11-13 | $1.43M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $339.00K 10-Q · filed 2025-08-12 | $729.00K 10-Q · filed 2025-08-12 | $1.20M derived: sum of 3 quarters · filed 2025-08-12 | $1.73M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $390.00K 10-Q · filed 2025-05-14 | $860.00K derived: sum of 2 quarters · filed 2025-05-14 | $1.39M derived: sum of 3 quarters · filed 2025-05-14 | $1.92M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $470.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $1.00M derived: sum of 2 quarters · filed 2025-03-10 | $1.53M derived: sum of 3 quarters · filed 2025-03-10 | $1.87M 10-K · filed 2025-03-10 |
| 2023-09-30 | $534.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.06M derived: sum of 2 quarters · filed 2024-11-07 | $1.40M 10-Q · filed 2024-11-07 | $1.68M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $529.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $864.00K 10-Q · filed 2024-08-08 | $1.14M derived: sum of 3 quarters · filed 2024-08-08 | $1.35M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $335.00K 10-Q · filed 2024-05-15 | $613.00K derived: sum of 2 quarters · filed 2024-05-15 | $820.00K derived: sum of 3 quarters · filed 2024-05-15 | $837.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $485.00K derived: sum of 2 quarters · filed 2024-03-28 | $502.00K derived: sum of 3 quarters · filed 2024-03-28 | $506.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $207.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $224.00K derived: sum of 2 quarters · filed 2023-11-02 | $228.00K 10-Q · filed 2023-11-02 | $236.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $21.00K 10-Q · filed 2023-08-10 | $29.00K derived: sum of 3 quarters · filed 2023-08-10 | $41.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $4.00K 10-Q · filed 2023-05-11 | $12.00K derived: sum of 2 quarters · filed 2023-05-11 | $24.00K derived: sum of 3 quarters · filed 2023-05-11 | $39.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $20.00K derived: sum of 2 quarters · filed 2023-03-09 | $35.00K derived: sum of 3 quarters · filed 2023-03-09 | $44.00K 10-K · filed 2023-03-09 |
| 2021-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $27.00K derived: sum of 2 quarters · filed 2022-11-14 | $36.00K 10-Q · filed 2022-11-14 | $46.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $24.00K 10-Q · filed 2022-08-15 | $34.00K derived: sum of 3 quarters · filed 2022-08-15 | $49.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $9.00K 10-Q · filed 2022-05-12 | $19.00K derived: sum of 2 quarters · filed 2022-05-12 | $34.00K derived: sum of 3 quarters · filed 2022-05-12 | $35.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $25.00K derived: sum of 2 quarters · filed 2022-03-22 | $26.00K derived: sum of 3 quarters · filed 2022-03-22 | $61.00K 10-K · filed 2022-03-22 |
| 2020-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $16.00K derived: sum of 2 quarters · filed 2021-11-15 | $51.00K 10-Q · filed 2021-11-15 | $67.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $36.00K 10-Q · filed 2021-08-16 | $52.00K derived: sum of 3 quarters · filed 2021-08-16 | $52.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $35.00K 10-Q · filed 2021-05-17 | $51.00K derived: sum of 2 quarters · filed 2021-05-17 | $51.00K derived: sum of 3 quarters · filed 2021-05-17 | |
| 2019-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $16.00K derived: sum of 2 quarters · filed 2021-03-09 | $16.00K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-12 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |